Business · 06/09/2018

FDA Releases Guidance for Developing Drug Products for Allergic Rhinitis Treatment

The US Food and Drug Administration (FDA) has published a guidance document to help pharmaceutical companies develop effective treatments for allergic rhinitis in children and adults, addressing trial design, effectiveness, and safety for new products targeting seasonal and perennial forms of the condition.